Saumya S Gurbani1,2,3, Eduard Schreibmann1,3, Andrew A Maudsley4, James Scott Cordova1,3, Brian J Soher5, Harish Poptani6, Gaurav Verma7, Peter B Barker8, Hyunsuk Shim1,2,3,9, Lee A D Cooper2,3,10. 1. Department of Radiation Oncology, Emory University, Atlanta, Georgia. 2. Wallace H. Coulter Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, Georgia. 3. Winship Cancer Institute of Emory University, Atlanta, Georgia. 4. Department of Radiology, University of Miami Miller School of Medicine, Miami, Florida. 5. Department of Radiology, Duke University School of Medicine, Durham, North Carolina. 6. Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom. 7. Department of Radiology, Icahn School of Medicine at Mt. Sinai, New York, New York. 8. Department of Radiology and Radiological Science, The Johns Hopkins University, Baltimore, Maryland. 9. Department of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia. 10. Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, Georgia.
Abstract
PURPOSE: Proton MRSI is a noninvasive modality capable of generating volumetric maps of in vivo tissue metabolism without the need for ionizing radiation or injected contrast agent. Magnetic resonance spectroscopic imaging has been shown to be a viable imaging modality for studying several neuropathologies. However, a key hurdle in the routine clinical adoption of MRSI is the presence of spectral artifacts that can arise from a number of sources, possibly leading to false information. METHODS: A deep learning model was developed that was capable of identifying and filtering out poor quality spectra. The core of the model used a tiled convolutional neural network that analyzed frequency-domain spectra to detect artifacts. RESULTS: When compared with a panel of MRS experts, our convolutional neural network achieved high sensitivity and specificity with an area under the curve of 0.95. A visualization scheme was implemented to better understand how the convolutional neural network made its judgement on single-voxel or multivoxel MRSI, and the convolutional neural network was embedded into a pipeline capable of producing whole-brain spectroscopic MRI volumes in real time. CONCLUSION: The fully automated method for assessment of spectral quality provides a valuable tool to support clinical MRSI or spectroscopic MRI studies for use in fields such as adaptive radiation therapy planning.
PURPOSE: Proton MRSI is a noninvasive modality capable of generating volumetric maps of in vivo tissue metabolism without the need for ionizing radiation or injected contrast agent. Magnetic resonance spectroscopic imaging has been shown to be a viable imaging modality for studying several neuropathologies. However, a key hurdle in the routine clinical adoption of MRSI is the presence of spectral artifacts that can arise from a number of sources, possibly leading to false information. METHODS: A deep learning model was developed that was capable of identifying and filtering out poor quality spectra. The core of the model used a tiled convolutional neural network that analyzed frequency-domain spectra to detect artifacts. RESULTS: When compared with a panel of MRS experts, our convolutional neural network achieved high sensitivity and specificity with an area under the curve of 0.95. A visualization scheme was implemented to better understand how the convolutional neural network made its judgement on single-voxel or multivoxel MRSI, and the convolutional neural network was embedded into a pipeline capable of producing whole-brain spectroscopic MRI volumes in real time. CONCLUSION: The fully automated method for assessment of spectral quality provides a valuable tool to support clinical MRSI or spectroscopic MRI studies for use in fields such as adaptive radiation therapy planning.
Authors: James S Cordova; Hui-Kuo G Shu; Zhongxing Liang; Saumya S Gurbani; Lee A D Cooper; Chad A Holder; Jeffrey J Olson; Brad Kairdolf; Eduard Schreibmann; Stewart G Neill; Constantinos G Hadjipanayis; Hyunsuk Shim Journal: Neuro Oncol Date: 2016-03-15 Impact factor: 12.300
Authors: Safoora Yousefi; Fatemeh Amrollahi; Mohamed Amgad; Chengliang Dong; Joshua E Lewis; Congzheng Song; David A Gutman; Sameer H Halani; Jose Enrique Velazquez Vega; Daniel J Brat; Lee A D Cooper Journal: Sci Rep Date: 2017-09-15 Impact factor: 4.379
Authors: Juan M García-Gómez; Jan Luts; Margarida Julià-Sapé; Patrick Krooshof; Salvador Tortajada; Javier Vicente Robledo; Willem Melssen; Elies Fuster-García; Iván Olier; Geert Postma; Daniel Monleón; Angel Moreno-Torres; Jesús Pujol; Ana-Paula Candiota; M Carmen Martínez-Bisbal; Johan Suykens; Lutgarde Buydens; Bernardo Celda; Sabine Van Huffel; Carles Arús; Montserrat Robles Journal: MAGMA Date: 2008-11-07 Impact factor: 2.310
Authors: Saumya S Gurbani; Sulaiman Sheriff; Andrew A Maudsley; Hyunsuk Shim; Lee A D Cooper Journal: Magn Reson Med Date: 2019-01-21 Impact factor: 4.668
Authors: Mohamad Abdi; Xue Feng; Changyu Sun; Kenneth C Bilchick; Craig H Meyer; Frederick H Epstein Journal: Magn Reson Med Date: 2021-05-22 Impact factor: 3.737
Authors: Peter C M van Zijl; Kevin Brindle; Hanzhang Lu; Peter B Barker; Richard Edden; Nirbhay Yadav; Linda Knutsson Journal: Curr Opin Chem Biol Date: 2021-07-20 Impact factor: 8.972
Authors: Saumya Gurbani; Brent Weinberg; Lee Cooper; Eric Mellon; Eduard Schreibmann; Sulaiman Sheriff; Andrew Maudsley; Mohammed Goryawala; Hui-Kuo Shu; Hyunsuk Shim Journal: Tomography Date: 2019-03
Authors: Vishwa S Parekh; Katarzyna J Macura; Susan C Harvey; Ihab R Kamel; Riham Ei-Khouli; David A Bluemke; Michael A Jacobs Journal: Med Phys Date: 2019-11-22 Impact factor: 4.071
Authors: Sofie Tapper; Mark Mikkelsen; Blake E Dewey; Helge J Zöllner; Steve C N Hui; Georg Oeltzschner; Richard A E Edden Journal: Magn Reson Med Date: 2020-11-18 Impact factor: 4.668
Authors: Andrew A Maudsley; Ovidiu C Andronesi; Peter B Barker; Alberto Bizzi; Wolfgang Bogner; Anke Henning; Sarah J Nelson; Stefan Posse; Dikoma C Shungu; Brian J Soher Journal: NMR Biomed Date: 2020-04-29 Impact factor: 4.044